At 50, SAS is publicly mapping an AI-first strategy while executives say they've prepped systems for a potential IPO — but founder Jim Goodnight still calls the timing.

The FDA tapped seven companies — including Eli Lilly and Regeneron — for a PreCheck pilot to speed reviews of new U.S. drug plants. The cohort includes big pharma and specialized CDMOs.

Durham-based Wolfspeed has dropped its federal breach‑of‑contract suit against Jaguar Land Rover over a failed silicon‑carbide supply agreement. Public details and any settlement terms were not disclosed.